New York Life Investment Management’s Crocs CROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,570
Closed -$465K 795
2025
Q3
$465K Sell
5,570
-180
-3% -$16.4K ﹤0.01% 777
2025
Q2
$582K Sell
5,750
-372
-6% -$37.9K 0.01% 744
2025
Q1
$650K Sell
6,122
-58
-0.9% -$6.01K 0.01% 734
2024
Q4
$677K Sell
6,180
-659
-10% -$76.7K 0.01% 747
2024
Q3
$990K Sell
6,839
-392
-5% -$53.5K 0.01% 701
2024
Q2
$1.06M Buy
7,231
+657
+10% +$92.2K 0.01% 667
2024
Q1
$945K Sell
6,574
-338
-5% -$38.5K 0.01% 687
2023
Q4
$646K Buy
6,912
+435
+7% +$40.2K 0.01% 756
2023
Q3
$571K Buy
6,477
+3,446
+114% +$354K 0.01% 746
2023
Q2
$341K Buy
+3,031
New +$361K ﹤0.01% 1183

Other funds holding CROX

New York Life Investment Management's CROX Position: Q4 2025 in Review

New York Life Investment Management sold out of Crocs (CROX) in Q4 2025, closing a stake of 5,570 shares — an estimated $465K sold.

New York Life Investment Management first reported a position in CROX in Q2 2023 and held it in 10 quarters. The position peaked at $1.06M in Q2 2024. 462 funds tracked by Wall St. Rank hold CROX as of Q4 2025.

  • New York Life Investment Management reported no remaining Crocs position as of Q4 2025 after selling out during the quarter.
  • New York Life Investment Management sold 5,570 Crocs shares in Q4 2025, an estimated $465K.
  • New York Life Investment Management first reported a position in Crocs in Q2 2023 and held it in 10 quarters.
  • New York Life Investment Management's Crocs position peaked at $1.06M in Q2 2024.
  • 462 funds tracked by Wall St. Rank held Crocs as of Q4 2025.

Based on New York Life Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.